Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 16, 2023; 11(17): 4026-4034
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4026
Published online Jun 16, 2023. doi: 10.12998/wjcc.v11.i17.4026
Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
Li-Min Jin, Hui Shen, Xing-Ying Che, Ye Jin, Chun-Mei Yuan, Neng-Hua Zhang, Laboratory Department, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing 314001, Zhejiang Province, China
Author contributions: Jin LM is mainly responsible for experimental design and writing articles; Shen H is mainly responsible for collecting data and samples; Chen XY conducted experimental operations and conducted statistical analysis of articles; Jin Y and Yuan CM are responsible for specimen selection and experimental operations; Zhang NH is responsible for experimental guidance and important revisions to the article, and all authors read and approved the final version.
Supported by Jiaxing Science and Technology Planning Project , No. 2019AY32006 and No. 2020AY30004 .
Institutional review board statement: The study was reviewed and approved by the Jiaxing Hospital of Traditional Chinese Medicine Institutional Review Board.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: There is no conflict of interest.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Neng-Hua Zhang, Doctor, Associate Chief Physician, Laboratory Department, Jiaxing Hospital of Traditional Chinese Medicine, No. 1501 Zhongshan East Road, Jiaxing 314001, Zhejiang Province, China. znhshzyxwx@163.com
Received: March 28, 2023
Peer-review started: March 28, 2023
First decision: April 11, 2023
Revised: April 21, 2023
Accepted: May 12, 2023
Article in press: May 12, 2023
Published online: June 16, 2023
Processing time: 75 Days and 22.4 Hours
Peer-review started: March 28, 2023
First decision: April 11, 2023
Revised: April 21, 2023
Accepted: May 12, 2023
Article in press: May 12, 2023
Published online: June 16, 2023
Processing time: 75 Days and 22.4 Hours
Core Tip
Core Tip: Baicalin combined with tobramycin therapy shows potential as an effective treatment method for patients with carbapenem-resistant Pseudomonas aeruginosa infection, as it significantly down-regulates drug-resistant and biofilm-related genes.